pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Rakuten Medical appoints Hassan Danesi as chief medical officer, coming from Coherus Biosciences

Sep 25, 2026·read at STAT ↗Neutral

Rakuten Medical announced that Hassan Danesi will join the company as its new chief medical officer. The appointment was disclosed in a recent industry column.

Danesi previously served as vice president of clinical development at Coherus Biosciences, where he oversaw multiple late-stage programs. His experience includes leading clinical strategy and regulatory interactions.

The move adds senior clinical expertise to Rakuten Medical's leadership team as it expands its pipeline. The hiring reflects ongoing talent shifts within the pharmaceutical sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Up and down the ladder: The latest comings and goings”

read at STAT ↗
458 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Rakuten Medical Inc3COHERUS BIOSCIENCES INC2LEADINGLILLYNOVORISING

related stories

  • Sep 9Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and MarketsBioSpace
  • Aug 2STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricingSTAT
  • Jul 2The new presidential fitness test is a positive step, not the solution, experts saySTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • 2d agoNovo workforce down 13,000BioSpace